Pharmaceutical giant says its vaccine only "may be" effective in reducing "severe disease and hospitalization," and falls short of confirming protection from infection.
In November 2017, the U.S. Environmental Protection Agency announced that MosquitoMate, Inc. had submitted plans to infect live male mosquitoes with a bacteria called "Wolbachia pipientis," which enhances WNV infection.
The Wisconsin Senate Committee on Shared Revenue, Elections and Consumer Protection held a hearing debating the consideration of nominating a new Administrator of Elections.
